Deprince Race & Zollo Inc. Purchases 36,072 Shares of Smith & Nephew SNATS, Inc. $SNN

Key Points

• Deprince Race & Zollo Inc. increased its position in Smith & Nephew by 10.6% in Q4, purchasing 36,072 shares to bring its stake to 375,955 shares worth about $12.34 million (≈0.09% of the company).
• Dividend announced: Smith & Nephew declared a $0.482 per share dividend, with an ex-dividend date of March 27 and payment on May 27; the article reports this represents a yield of 304.0%.
• Analyst consensus: one analyst rates the stock a Strong Buy and four rate it Hold, giving Smith & Nephew an average rating of "Hold" and an average price target of $36.25.

Deprince Race & Zollo Inc. increased its position in shares of Smith & Nephew SNATS, Inc. (NYSE:SNN - Free Report) by 10.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 375,955 shares of the medical equipment provider's stock after acquiring an additional 36,072 shares during the quarter. Deprince Race & Zollo Inc. owned about 0.09% of Smith & Nephew SNATS worth $12,335,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Caitong International Asset Management Co. Ltd bought a new position in shares of Smith & Nephew SNATS during the 3rd quarter worth approximately $41,000. Northwestern Mutual Wealth Management Co. raised its stake in shares of Smith & Nephew SNATS by 105.8% during the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 1,385 shares of the medical equipment provider's stock worth $50,000 after acquiring an additional 712 shares in the last quarter. Huntington National Bank raised its stake in shares of Smith & Nephew SNATS by 1,837.0% during the 3rd quarter. Huntington National Bank now owns 1,414 shares of the medical equipment provider's stock worth $51,000 after acquiring an additional 1,341 shares in the last quarter. Smartleaf Asset Management LLC raised its stake in shares of Smith & Nephew SNATS by 1,222.3% during the 3rd quarter. Smartleaf Asset Management LLC now owns 2,486 shares of the medical equipment provider's stock worth $88,000 after acquiring an additional 2,298 shares in the last quarter. Finally, Root Financial Partners LLC bought a new position in shares of Smith & Nephew SNATS during the 3rd quarter worth approximately $102,000. Institutional investors own 25.64% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on SNN shares. Wall Street Zen upgraded shares of Smith & Nephew SNATS from a "buy" rating to a "strong-buy" rating in a research note on Sunday, March 29th. Weiss Ratings restated a "hold (c+)" rating on shares of Smith & Nephew SNATS in a research note on Wednesday, January 21st. Royal Bank Of Canada lowered shares of Smith & Nephew SNATS from an "outperform" rating to a "sector perform" rating in a research note on Monday, December 15th. Finally, Canaccord Genuity Group upped their price target on shares of Smith & Nephew SNATS from $34.00 to $35.00 and gave the company a "hold" rating in a research note on Thursday, March 5th. One analyst has rated the stock with a Strong Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $36.25.

Smith & Nephew SNATS Trading Up 1.6%

Shares of Smith & Nephew SNATS stock opened at $34.01 on Tuesday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.25 and a current ratio of 2.57. Smith & Nephew SNATS, Inc. has a 12-month low of $25.45 and a 12-month high of $38.79. The firm's 50 day simple moving average is $34.09 and its two-hundred day simple moving average is $34.05.

Smith & Nephew SNATS (NYSE:SNN - Get Free Report) last issued its quarterly earnings results on Tuesday, February 17th. The medical equipment provider reported $29.55 earnings per share (EPS) for the quarter. The company had revenue of $1.60 billion for the quarter. As a group, analysts expect that Smith & Nephew SNATS, Inc. will post 1.69 earnings per share for the current fiscal year.

Smith & Nephew SNATS Announces Dividend

The business also recently declared a dividend, which will be paid on Wednesday, May 27th. Shareholders of record on Friday, March 27th will be paid a dividend of $0.482 per share. The ex-dividend date is Friday, March 27th. This represents a yield of 304.0%.

About Smith & Nephew SNATS

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.